BioRem (CVE:BRM) Shares Up 16% – Still a Buy?

BioRem Inc. (CVE:BRM) rose 16% during trading on Wednesday. The stock traded as high as C$4.41 and last traded at C$4.35. 100,846 shares were traded during trading, an increase of 339% from the average session volume of 22,966 shares. The stock had previously closed at C$3.75.

BioRem Price Performance

The firm has a market capitalization of C$70.82 million, a price-to-earnings ratio of 13.01 and a beta of 0.77. The stock’s fifty day moving average price is C$3.58 and its two-hundred day moving average price is C$3.11. The company has a current ratio of 2.04, a quick ratio of 1.08 and a debt-to-equity ratio of 14.17.

Insider Activity

In other news, Director Derek Webb sold 28,700 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of C$3.82, for a total value of C$109,634.00. Following the transaction, the director owned 362,370 shares in the company, valued at approximately C$1,384,253.40. This represents a 7.34% decrease in their position. Corporate insiders own 1.90% of the company’s stock.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.